Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amicus Therapeutics (FOLD) Non Operating Investment Income (2018)

Historic Non Operating Investment Income for Amicus Therapeutics (FOLD) over the last 1 years, with Q2 2018 value amounting to -$7.6 million.

  • Amicus Therapeutics' Non Operating Investment Income changed N/A to -$7.6 million in Q2 2018 from the same period last year, while for Jun 2019 it was -$7.6 million, marking a year-over-year change of. This contributed to the annual value of -$2.7 million for FY2018, which is N/A changed from last year.
  • Latest data reveals that Amicus Therapeutics reported Non Operating Investment Income of -$7.6 million as of Q2 2018.
  • Amicus Therapeutics' 5-year Non Operating Investment Income high stood at $4.9 million for Q1 2018, and its period low was -$7.6 million during Q2 2018.